A Study to Compare CAELYX With Topotecan HCL in Patients With Recurrent Epithelial Ovarian Carcinoma Following Failure of First-Line, Platinum-Based Chemotherapy

NCT01840943 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
32
Enrollment
INDUSTRY
Sponsor class

Stopped the study was terminated due to medication supply issue from current manufacturer

Conditions

Interventions

Sponsor

Xian-Janssen Pharmaceutical Ltd.